Structural basis of the gating mechanism of connexin 26 and related hearing loss
连接蛋白26门控机制及相关听力损失的结构基础
基本信息
- 批准号:10303738
- 负责人:
- 金额:$ 22.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-09 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsBiochemicalBiological AssayCalciumCalcium ionCalmodulinCell membraneCell physiologyCellsChemicalsClinicalComplexConnexinsCryoelectron MicroscopyDataDetergentsDyesEnvironmentFamilyFunctional disorderGJB2 geneGleanHearing problemHela CellsHumanHuman bodyIon ExchangeLeadLipidsMembraneMembrane ProteinsMolecularMolecular ConformationMutationOutcomePathologyPhysiologicalPhysiological ProcessesPlayPoint MutationPolymersProteinsProtocols documentationResolutionRoleSamplingSecond Messenger SystemsSenter syndromeSolidStructureSystemTestingTransmembrane Domainbasedeafdensitygap junction channelhearing impairmentimprovedinsightintercellular communicationinterestmembermutantnanoparticlenovel strategiesparticleprotein complexsmall moleculetherapeutic protein
项目摘要
SUMMARY
Connexin 26, as a gap junction channel, directly regulates the cell-to-cell exchange of ion,
metabolites, and second messengers. Mutations of connexin 26 can cause severe hearing loss.
However, the molecular gating mechanism on the structural basis of connexin 26 is still unclear,
especially the closed state and malfunction of connexin 26 mutations. We have developed the
native cell membrane nanoparticle (NCMN) system for high-resolution single-particle cryo-EM
structure determination and functional studies of membrane proteins within their physiological
conditions. We recently solved the cryo-EM structures of connexin 26 in the absence or presence
of calcium ions in an open state at 2.3 Å and 2.9 Å associated with about 36 lipid molecules via
the NCMN system. However, the close state of connexin 26 with high resolution is still uncovered.
We hypothesize that our NCMN system's application to structure determination of Cx26 and
Cx26-R75W in the presence and absence of calcium and calmodulin can provide unique
structural information. Aim 1: To investigate the CLOSED conformation of the gating mechanism
of Cx26. Aim 2: To elucidate the molecular basis of how the single point mutation R75W in Cx26
leads to profound hearing loss. The proposed experimental results will provide insights into
detailed structural information and biochemical analysis in understanding the gating mechanism,
also provide mechanistic details on abnormal channel gating function detected in this hearing
disorder. The structural information may lead to some novel strategy to modulate the malfunction
CX26-R75W for hearing loss.
总结
连接蛋白26作为间隙连接通道,直接调节细胞间的离子交换,
代谢物和第二信使。连接蛋白26的突变会导致严重的听力损失。
然而,连接蛋白26的结构基础上的分子门控机制仍然不清楚,
尤其是连接蛋白26突变的闭合状态和功能障碍。我们开发了
用于高分辨率单颗粒冷冻EM的天然细胞膜纳米颗粒(NCMN)系统
膜蛋白结构测定及其生理功能研究
条件我们最近解决了连接蛋白26的冷冻电镜结构,
在2.3 μ m和2.9 μ m的开放状态下,钙离子与约36个脂质分子通过
NCMN系统。然而,高分辨率的连接蛋白26的闭合状态仍然未被揭示。
我们假设我们的NCMN系统在Cx 26结构测定中的应用,
Cx 26-R75 W在钙和钙调蛋白存在和不存在下可以提供独特的
结构信息。目的1:研究门控机制的闭合构象
CX 26的目的2:阐明Cx 26基因单点突变R75 W的分子基础
导致严重的听力损失拟议的实验结果将提供见解,
详细的结构信息和生化分析,以了解门控机制,
还提供了在该听证会中检测到的异常通道门控功能的机制细节
disorder.结构信息可能会导致一些新的策略来调节故障
CX 26-R75 W用于治疗听力损失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Weihua Qiu其他文献
Weihua Qiu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Weihua Qiu', 18)}}的其他基金
Structural basis of the gating mechanism of connexin 26 and related hearing loss
连接蛋白26门控机制及相关听力损失的结构基础
- 批准号:
10448309 - 财政年份:2021
- 资助金额:
$ 22.9万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 22.9万 - 项目类别:
Continuing Grant
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Operating Grants
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Standard Grant
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
EAGER: Elastic Electronics for Sensing Gut Luminal and Serosal Biochemical Release
EAGER:用于感测肠腔和浆膜生化释放的弹性电子器件
- 批准号:
2334134 - 财政年份:2023
- 资助金额:
$ 22.9万 - 项目类别:
Standard Grant